Henry Schein, Inc. $HSIC Shares Bought by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 63.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,505 shares of the company’s stock after buying an additional 3,675 shares during the period. Sequoia Financial Advisors LLC’s holdings in Henry Schein were worth $694,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in HSIC. Steph & Co. acquired a new position in shares of Henry Schein in the second quarter valued at approximately $44,000. CX Institutional increased its holdings in shares of Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock valued at $48,000 after purchasing an additional 337 shares during the period. TD Private Client Wealth LLC increased its holdings in shares of Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock valued at $49,000 after purchasing an additional 339 shares during the period. Whittier Trust Co. increased its holdings in shares of Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after purchasing an additional 700 shares during the period. Finally, Quarry LP acquired a new position in shares of Henry Schein in the first quarter valued at approximately $71,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Up 1.5%

HSIC opened at $62.98 on Monday. The business’s fifty day moving average is $67.12 and its two-hundred day moving average is $68.60. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The company has a market cap of $7.64 billion, a price-to-earnings ratio of 20.32, a PEG ratio of 2.08 and a beta of 0.81. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion for the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter in the previous year, the firm posted $1.23 earnings per share. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HSIC. Stifel Nicolaus reissued a “hold” rating and issued a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Baird R W lowered Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Barrington Research reaffirmed an “outperform” rating and set a $78.00 price objective on shares of Henry Schein in a report on Tuesday, September 23rd. Evercore ISI raised Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price objective on the stock in a report on Tuesday, August 26th. Finally, UBS Group dropped their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. Five research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.